Ortet

Based in the US, Ortet, operates as a company that builds research biological, clinical, operational, and healthcare data to improve decision-making across research, care delivery, and health system operations. Based in New York, the US and founded in 2026, Ortet builds research biological, clinical, operational, and healthcare data to improve decision-making across research, care delivery, and health system operations. In September 2026, Ortet raised USD 500 mn in venture funding from Thoreau Group. The company will use the funding to build AI models for drug discovery, expand its computing and data infrastructure, and hire research and engineering teams to develop healthcare applications.

Ortet specializes in developing AI-driven health solutions aimed at delivering individualized patient care. Their core offering, the Ortet Health Model, integrates biological, clinical, and operational information to predict health outcomes and identify interventions for improved care. Ortet's solutions are utilized by healthcare institutions and practitioners, focusing on democratizing access to precise and affordable healthcare for diverse populations. Ortet's revenue model is structured around partnerships and collaborations with healthcare institutions and clinicians.

The company provides subscription-based access to its AI-driven health modeling and analytics services, enhancing patient care and operational efficiency through contractual agreements with clients. The company plans to build AI models for drug discovery, expand its computing and data infrastructure, and hire research and engineering teams to develop healthcare applications.